Enveric Biosciences (ENVB)
(Delayed Data from NSDQ)
$0.53 USD
-0.01 (-0.94%)
Updated Jul 16, 2024 03:59 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ENVB 0.53 -0.01(-0.94%)
Will ENVB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ENVB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENVB
Enveric Biosciences, Inc. (ENVB) Stock Falls Amid Market Uptick: What Investors Need to Know
Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors
ENVB: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for April 17th
What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock
New Strong Buy Stocks for April 12th
Other News for ENVB
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
Enveric Biosciences Announces Patent Granted for Drug Candidate
Here's What You Missed in Cannabis, Psychedelics This Week
Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
Enveric Biosciences prioritizes development of EB-003